January 23, 2024 Comments Off on New patent expiration for Cubist Pharms drug DIFICID Posted in: Uncategorized
Annual Drug Patent Expirations for DIFICID Dificid is a drug marketed by Cubist Pharms Llc and is included in two NDAs. It is available from one supplier. There are six…
The post New patent expiration for Cubist Pharms drug DIFICID appeared first on Dr…
January 23, 2024 Comments Off on New patent expiration for MYLAN drug EVOCLIN Posted in: Uncategorized
Annual Drug Patent Expirations for EVOCLIN Evoclin is a drug marketed by Mylan and is included in one NDA. There are two patents protecting this drug and one Paragraph IV…
The post New patent expiration for MYLAN drug EVOCLIN appeared first on DrugPate…
